Trial Profile

Open-Label Pilot Trial to Evaluate the Effects of Ilofotase Alfa on Biomarkers in Adult Patients With Hypophosphatasia

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 03 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ilofotase alfa (Primary)
Indications Hypophosphatasia
Focus Biomarker; Pharmacodynamics
Sponsors AM-Pharma

Most Recent Events

30 Nov 2023 Status changed from recruiting to completed.
11 Oct 2023 According to an AM-Pharma media release, Lothar Seefried, MD, from the University of Wuerzburg, lead investigator of this trial.
11 Oct 2023 Results presented in a AM-Pharma media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com